GlaxoSmithKline (GSK) announced that the company is restoring the original savings levels offered on its medicines through the Orange Card program. The company also will reimburse cardholders who purchased GSK medicines using their Orange Card during the period from October 1 through mid-November. Checks will be sent to eligible cardholders in an amount equal to the difference between the program's original savings level and the amended savings level.
In October 1, GSK lowered the savings levels it offered on its outpatient medicines through the Orange Card and Together Rx programs because of uncertainties about how these programs would be treated under government pricing regulations. Last month, these pricing issues related to the Together Rx were resolved and, recently, Medicare officials clarified their position on the GlaxoSmithKline's Orange Card program. "More than 100,000 seniors have benefited from the savings they get by using the Orange Card," said Robert Ingram, GSK's chief operating officer and President, Pharmaceuticals. "I am delighted that we're now able to restore Orange Card savings levels for these Medicare recipients who enjoy the benefits of their Orange Cards."
The administrator of the card program will process checks to eligible Orange Card enrollees. No action is needed on the part of those who used their Orange Card to purchase GSK medicines during the period of amended savings - checks will be sent automatically.